Sage Private Wealth Group LLC Increases Holdings in Medtronic PLC $MDT

by · The Cerbat Gem

Sage Private Wealth Group LLC grew its position in shares of Medtronic PLC (NYSE:MDT – Free Report) by 16.8% during the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 4,072 shares of the medical technology company’s stock after acquiring an additional 587 shares during the quarter. Sage Private Wealth Group LLC’s holdings in Medtronic were worth $355,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently modified their holdings of the company. Stratos Investment Management LLC increased its position in Medtronic by 1.0% during the second quarter. Stratos Investment Management LLC now owns 32,997 shares of the medical technology company’s stock valued at $2,876,000 after acquiring an additional 317 shares during the last quarter. Smithbridge Asset Management Inc. DE grew its stake in shares of Medtronic by 3.6% during the 2nd quarter. Smithbridge Asset Management Inc. DE now owns 62,418 shares of the medical technology company’s stock valued at $5,441,000 after purchasing an additional 2,140 shares during the period. Tower Wealth Partners Inc. bought a new stake in shares of Medtronic during the 2nd quarter valued at about $224,000. Turtle Creek Wealth Advisors LLC purchased a new stake in shares of Medtronic during the 2nd quarter valued at about $294,000. Finally, Nvest Financial LLC lifted its stake in shares of Medtronic by 6.6% in the 2nd quarter. Nvest Financial LLC now owns 11,272 shares of the medical technology company’s stock worth $983,000 after purchasing an additional 696 shares during the period. Institutional investors own 82.06% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently issued reports on MDT. UBS Group boosted their target price on shares of Medtronic from $94.00 to $95.00 and gave the company a “neutral” rating in a research report on Wednesday, August 20th. Weiss Ratings reissued a “buy (b-)” rating on shares of Medtronic in a research report on Wednesday, October 8th. Wolfe Research upgraded Medtronic from an “underperform” rating to a “peer perform” rating in a research note on Monday, June 30th. Morgan Stanley reiterated an “overweight” rating and set a $107.00 target price (up from $98.00) on shares of Medtronic in a research report on Tuesday, July 15th. Finally, Daiwa Capital Markets boosted their price target on Medtronic from $101.00 to $104.00 and gave the company a “buy” rating in a report on Friday, September 12th. One analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating, nine have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $102.82.

Read Our Latest Stock Report on MDT

Medtronic Stock Performance

NYSE:MDT opened at $94.98 on Friday. The company has a current ratio of 2.01, a quick ratio of 1.50 and a debt-to-equity ratio of 0.54. Medtronic PLC has a 12-month low of $79.29 and a 12-month high of $99.37. The stock has a 50-day moving average price of $94.01 and a 200 day moving average price of $88.93. The stock has a market capitalization of $121.83 billion, a P/E ratio of 26.17, a P/E/G ratio of 2.51 and a beta of 0.78.

Medtronic (NYSE:MDT – Get Free Report) last posted its quarterly earnings results on Tuesday, August 19th. The medical technology company reported $1.26 EPS for the quarter, topping analysts’ consensus estimates of $1.23 by $0.03. Medtronic had a return on equity of 14.61% and a net margin of 13.63%.The company had revenue of $8.58 billion for the quarter, compared to analysts’ expectations of $8.37 billion. During the same period in the previous year, the firm earned $1.23 EPS. The firm’s revenue was up 7.7% compared to the same quarter last year. Medtronic has set its FY 2026 guidance at 5.600-5.660 EPS. Equities research analysts forecast that Medtronic PLC will post 5.46 EPS for the current fiscal year.

Medtronic Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, October 17th. Investors of record on Friday, September 26th will be given a dividend of $0.71 per share. The ex-dividend date is Friday, September 26th. This represents a $2.84 dividend on an annualized basis and a dividend yield of 3.0%. Medtronic’s dividend payout ratio is currently 78.24%.

Insider Buying and Selling at Medtronic

In other news, Director William R. Jellison acquired 2,500 shares of the business’s stock in a transaction dated Monday, August 25th. The stock was purchased at an average price of $92.37 per share, for a total transaction of $230,925.00. Following the completion of the transaction, the director directly owned 5,000 shares in the company, valued at approximately $461,850. This trade represents a 100.00% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Harry Skip Kiil sold 8,605 shares of Medtronic stock in a transaction dated Wednesday, September 3rd. The stock was sold at an average price of $91.58, for a total value of $788,045.90. Following the completion of the sale, the executive vice president directly owned 35,615 shares in the company, valued at $3,261,621.70. This trade represents a 19.46% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.26% of the company’s stock.

Medtronic Company Profile

(Free Report)

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.

Featured Articles

Want to see what other hedge funds are holding MDT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic PLC (NYSE:MDT – Free Report).